miRNA papers vs Grok’s theories (8)

(click to enlarge)

miRNA papers vs Grok’s theories (7)

“Intelligent people will link these findings to 91,221 results from today’s PubMed search for indexed articles that mention miRNA and cancer.

Elon Musk’s “most dangerous chatbot” will continue to deny the facts from Nutrient-dependent Pheromone-Controlled Ecological Adaptations: From Angstroms to Ecosystems (4/18/18), and contribute to more unnecessary suffering and premature deaths.”

Scoolam Foundation wrote: “Photosynthesis is the process by which green plants, algae, and some bacteria use sunlight to make food from carbon dioxide and water. Inside chloroplasts, chlorophyll captures light energy to produce glucose while releasing oxygen as a byproduct. This life-supporting process provides energy for plants and oxygen for most living organisms on Earth.”

New England Journal of Medicine wrote: “NEJM editors highlight three aspects of OMB’s recently proposed rule changes as particularly striking: that decisions on research funding would be made by political appointees, that funding could be cut off midway through a grant period, and that foreign interactions would be severely limited.”

Lewis Thomas linked the pheromone regulated physiology of reproduction to all biodiversity on Earth in his NEJM Series published in book form as The Lives of a Cell: Notes of a Biology Watcher 5/31/74

“Elegant, suggestive, and clarifying, Lewis Thomas’s profoundly humane vision explores the world around us and examines the complex interdependence of all things. Extending beyond the usual limitations of biological science and into a vast and wondrous world of hidden relationships, this provocative book explores in personal, poetic essays to topics such as computers, germs, language, music, death, insects, and medicine. Lewis Thomas writes, “Once you have become permanently startled, as I am, by the realization that we are a social species, you tend to keep an eye out for the pieces of evidence that this is, by and large, good for us.”

See also: A Fear of Pheromones 8/12/71

“WHAT are we going to do if it turns out that we have pheromones? What on earth would we be doing with such things? With the richness of speech, and all our new devices for communication, why would we want to release odors into the air to convey information about anything?”

See also: Engineering & Science 6/16/26
Dr. Patrick Soon-Shiong is a billionaire physician-scientist, entrepreneur, and the founder of ImmunityBio. Throughout his career, he has focused on developing innovative treatments aimed at helping the body’s own immune system fight disease. One of his most notable developments is Anktiva (N-803), an immunotherapy designed to support the body’s natural defenses against c@ncer.
Unlike traditional treatments that often rely heavily on chemotherapy, Anktiva was developed with a different approach. Instead of directly attacking c@ncer cells with powerful chemicals, the therapy works by stimulating key parts of the immune system. Its goal is to help the body recognize and respond to abnormal cells more effectively.
Anktiva functions as an IL-15 receptor superagonist, a technology designed to activate and strengthen important immune cells. Among these are Natural Killer (NK) cells, which serve as one of the body’s first lines of defense. These cells constantly patrol the body, searching for infected, damaged, or abnormal cells that may pose a threat. When activated, NK cells can identify and destroy c@ncerous cells before they spread further.
The therapy also enhances the activity of cytotoxic T-cells, another critical component of the immune system. These specialized cells are responsible for locating and eliminating cells that have become harmful. By boosting both NK cells and cytotoxic T-cells, Anktiva aims to strengthen the body’s natural ability to target c@ncer cells.
This approach reflects a broader shift in modern medicine toward immunotherapy, where treatments are designed to work with the immune system rather than relying solely on conventional methods. Researchers believe that empowering the body’s own defenses may offer new possibilities for treating certain forms of c@ncer while reducing dependence on more aggressive therapies.
Dr. Soon-Shiong’s work has attracted worldwide attention because it focuses on harnessing the immune system’s natural capabilities. His vision is based on the idea that the body’s defense network already possesses powerful tools for fighting disease and that advanced therapies can help unlock that potential.
Today, Anktiva is recognized as one of the notable developments in the field of immunotherapy. Its focus on activating Natural Killer cells and cytotoxic T-cells represents a different strategy in the ongoing effort to improve c@ncer treatment and expand the options available to patients around the world.

Was his patent for Abraxane linked to metastasis via PGx and NGs testing to differentiate between somatic and genetic mutations?

Subscribe

Login

Notify of

new follow-up comments new replies to my comments

Label

{} [+]

Name*

Email*

Website

Label

{} [+]

Name*

Email*

Website

0 Comments

Oldest

Newest Most Voted

Want more on the same topic?

Swipe/Drag Left and Right To Browse Related Posts: